Social media discourse and internet search queries on cannabis as a medicine: A systematic review

Competing Interest Statement

Yvonne Bonomo is a Principal Investigator on an open label study to evaluate the safety, tolerability, and pharmacokinetics of a medicinal cannabinoid oil formulation in chronic non-cancer pain patients for Zelira Therapeutics ACTRN12619001013156.

Funding Statement

This work was undertaken as part of the MDRP program as part of Melbourne Medical School, Department of General Practice at the University of Melbourne, and the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE) is established through the National Health and Medical Research Council (NHMRC) Centre of Research Excellence scheme. It draws together over twenty Australian research leaders and clinicians from major national universities and research institutions to establish a research evidence base to inform safe clinical use of medicinal cannabinoids and to guide policy as cannabinoids are introduced into therapeutic practice in Australia.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Not Applicable